Health: Ban on unlicensed peptide products
The Ministry of Public Health in Qatar has prohibited the trading, importing, and use of unlicensed peptide products, such as BPC-157, Retatrutide, and MOTS-c, which are being illegally marketed and promoted with claims of medical, cosmetic, or performance-enhancing benefits without official approvals. The Ministry reaffirmed that these products are not yet authorized for human use and that their use could pose health risks to patients, as their safety and efficacy have not been demonstrated. It also emphasized that all forms of promotion, including through social media, are strictly prohibited, and strict measures will be taken against violators to ensure the protection of public health.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)